76 related articles for article (PubMed ID: 3209828)
1. [Determination of the growth fraction using monoclonal antibody Ki-67 in breast cancers].
Lellé RJ; Heidenreich W; Borsi C; Stauch G; Gerdes J
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(4):485-9. PubMed ID: 3209828
[TBL] [Abstract][Full Text] [Related]
2. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
Lellé RJ
Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
[TBL] [Abstract][Full Text] [Related]
3. Growth fractions (Ki-67) in primary breast cancers, with particular reference to node-negative tumors.
Weikel W; Brumm C; Wilkens C; Beck T; Knapstein PG
Cancer Detect Prev; 1995; 19(5):446-50. PubMed ID: 7585732
[TBL] [Abstract][Full Text] [Related]
4. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
Kunz J; Schmidt A
Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
6. The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma.
Lellé RJ; Heidenreich W; Stauch G; Gerdes J
Cancer; 1987 Jan; 59(1):83-8. PubMed ID: 2431758
[TBL] [Abstract][Full Text] [Related]
7. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.
van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
Cancer Res; 1989 Jun; 49(11):2999-3006. PubMed ID: 2720660
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1.
Kreipe H; Alm P; Olsson H; Hauberg M; Fischer L; Parwaresch R
Am J Pathol; 1993 Feb; 142(2):651-7. PubMed ID: 8094598
[TBL] [Abstract][Full Text] [Related]
9. Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-phase fraction in breast carcinoma.
MacGrogan G; Jollet I; Huet S; Sierankowski G; Picot V; Bonichon F; Coindre JM
Mod Pathol; 1997 Aug; 10(8):769-76. PubMed ID: 9267818
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
11. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
12. [DNA content analysis of breast cancer cells recognized by monoclonal antibody].
Zhu LW
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):347-50. PubMed ID: 8174478
[TBL] [Abstract][Full Text] [Related]
13. Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining.
Raymond WA; Leong AS; Bolt JW; Milios J; Jose JS
J Pathol; 1988 Oct; 156(2):161-7. PubMed ID: 3058914
[TBL] [Abstract][Full Text] [Related]
14. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
[TBL] [Abstract][Full Text] [Related]
15. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
17. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
18. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
Kunz J
Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells].
Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastases displaying lower Ki-67 immunostaining activity than the primary breast cancer.
Cabibi D; Mustacchio V; Martorana A; Tripodo C; Campione M; Calascibetta A; Sanguedolce R; Aragona F
Anticancer Res; 2006; 26(6B):4357-60. PubMed ID: 17201155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]